DE602004012207D1 - Fluoreszent markierte Ghrelin-Peptide - Google Patents

Fluoreszent markierte Ghrelin-Peptide

Info

Publication number
DE602004012207D1
DE602004012207D1 DE602004012207T DE602004012207T DE602004012207D1 DE 602004012207 D1 DE602004012207 D1 DE 602004012207D1 DE 602004012207 T DE602004012207 T DE 602004012207T DE 602004012207 T DE602004012207 T DE 602004012207T DE 602004012207 D1 DE602004012207 D1 DE 602004012207D1
Authority
DE
Germany
Prior art keywords
fluorescently labeled
ghrelin peptides
labeled ghrelin
peptides
fluorescently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004012207T
Other languages
English (en)
Other versions
DE602004012207T2 (de
Inventor
Thilo Enderle
Martin Graf
Cornelia Hertel
Sannah Jensen Zoffmann
Eric Argirios Kitas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE602004012207D1 publication Critical patent/DE602004012207D1/de
Application granted granted Critical
Publication of DE602004012207T2 publication Critical patent/DE602004012207T2/de
Anticipated expiration legal-status Critical
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
    • G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602004012207T 2003-10-16 2004-10-08 Fluoreszent markierte Ghrelin-Peptide Active DE602004012207T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03023568 2003-10-16
EP03023568 2003-10-16

Publications (2)

Publication Number Publication Date
DE602004012207D1 true DE602004012207D1 (de) 2008-04-17
DE602004012207T2 DE602004012207T2 (de) 2009-03-12

Family

ID=34429239

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004012207T Active DE602004012207T2 (de) 2003-10-16 2004-10-08 Fluoreszent markierte Ghrelin-Peptide

Country Status (6)

Country Link
US (2) US7173109B2 (de)
JP (1) JP4293971B2 (de)
CN (1) CN1637416B (de)
CA (1) CA2480199C (de)
DE (1) DE602004012207T2 (de)
ES (1) ES2300686T3 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007038678A2 (en) * 2005-09-28 2007-04-05 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Analogs of ghrelin
US8299022B2 (en) * 2006-09-27 2012-10-30 Ipsen Pharma S.A.S. Analogs of ghrelin substituted at the N-terminal
US8623326B2 (en) * 2008-05-23 2014-01-07 University Of Western Ontario Ghrelin analogues
WO2013155633A1 (en) * 2012-04-19 2013-10-24 Leong Hon Sing Method for detecting or monitoring prostate cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60042527D1 (de) 1999-11-22 2009-08-20 Zymogenetics Inc Methode zur bildung einen peptid-rezeptor komplex mit zsig33 polypeptiden.
US6967237B2 (en) 2000-05-30 2005-11-22 Merck & Co., Inc. Ghrelin analogs
WO2002008250A2 (en) * 2000-07-24 2002-01-31 Ardana Bioscience Limited Ghrelin antagonists
WO2003072753A2 (en) * 2002-02-27 2003-09-04 Emory University Multimeric binding complexes
JP2006502227A (ja) * 2002-10-07 2006-01-19 ザイモジェネティクス，インコーポレイティド 体重調節方法

Also Published As

Publication number Publication date
CA2480199C (en) 2013-03-12
CN1637416B (zh) 2011-08-17
ES2300686T3 (es) 2008-06-16
CN1637416A (zh) 2005-07-13
CA2480199A1 (en) 2005-04-16
JP4293971B2 (ja) 2009-07-08
DE602004012207T2 (de) 2009-03-12
US7186798B2 (en) 2007-03-06
US20050085421A1 (en) 2005-04-21
US7173109B2 (en) 2007-02-06
US20060073522A1 (en) 2006-04-06
JP2005120093A (ja) 2005-05-12

Similar Documents

Publication Publication Date Title
FI20021043A (fi) Sekvenssiperusteinen paikannustekniikka
DE60323182D1 (de) Authentifizierungssystem
DK1663936T3 (da) Biaryloxymethylaren-carboxylsyrer
DE502004010381D1 (de) Um
DE60323899D1 (de) Startvorrichtung
SE0302091L (sv) Genomföring
DE60311728D1 (de) Motorträger
ATE462365T1 (de) Marknagel
ATE397618T1 (de) Peptidcyclisierung
DE60331275D1 (de) Kraftstoffpumpe
IS7862A (is) Verkjalyf
ATE375761T1 (de) Marknagel
DE60318073D1 (de) Gruppensignaturschema
NO20043704L (no) Belysningssystem
DE602004018247D1 (de) Modulator
DE502004002994D1 (de) Anfahreinheit
DE502004002714D1 (de) Anfahreinheit
NO20026285D0 (no) Nye peptider
DE602004012207D1 (de) Fluoreszent markierte Ghrelin-Peptide
ATA4032002A (de) Fahnenmast
DK1625148T3 (da) Peptidkompleks
DE50305471D1 (de) Kraftstoffpumpe
DE502004000459D1 (de) Gasgeneratorbaugruppe
NO20050436D0 (no) Beta-lagnedbrytende peptider
NO20053512D0 (no) IL-8-liknende proteiner

Legal Events

Date Code Title Description
8364 No opposition during term of opposition